Opening Plenary – State of Innovation
January 17, 2025

Opening Plenary – State of Innovation

Date and time

January 23, 2025 ~ January 31, 2025

The Opening Plenary of the 13th annual WuXi Global Forum brought together an extraordinary panel of industry leaders to explore the State of Innovation and the transformative potential of new solutions in healthcare. Their thoughtful insights set the tone for the entire forum, sparking meaningful discussions about the challenges and opportunities ahead.


We are honored to feature:

Antoine Papiernik, Chairman and Managing Partner, Sofinnova Partners

Frank Nestle, Partner and CEO of 3DC, Deerfield Management

Mathai Mammen, CEO, President and Chairman, Parabilis Medicines 

Nina Kjellson, General Partner, Canaan Partners

Stephen Squinto, Chief Investment Officer, JP Morgan Life Science Private Capital

Uli Stilz, Head of Bio Innovation Hub, Novo Nordisk

Session Leader: Steve Yang, Co-CEO, WuXi AppTec


In this dynamic session, panelists discussed bold strategies, emerging trends, and the critical innovations poised to shape the future of healthcare. From groundbreaking advancements in science to the power of collaboration, their perspectives highlighted how every innovation story matters and how collectively, we can deliver life-changing breakthroughs for patients.


This plenary is a celebration of leadership, vision, and the collaborative spirit that drives our industry forward. 


The Digital WuXi Global Forum 2025, available only from January 23 to January 31, has now concluded. We look forward to welcoming you again next year.


Related Links: 

Experience the Energy – Recap Video

WuXi Global Forum 2025 Agenda 

Speakers
  • Antoine Papiernik
    Antoine Papiernik
    Chairman and Managing Partner, Sofinnova Partners
  • Frank Nestle
    Frank Nestle
    Partner and CEO of 3DC, Deerfield Management
  • Mathai Mammen
    Mathai Mammen
    CEO, President and Chairman, Parabilis Medicines
  • Nina Kjellson
    Nina Kjellson
    General Partner, Canaan Partners
  • Stephen Squinto
    Stephen Squinto
    Chief Investment Officer, JP Morgan Life Science Private Capital
  • Uli Stilz
    Uli Stilz
    Head of Bio Innovation Hub, Novo Nordisk
  • Steve Yang
    Steve Yang
    Co-CEO, WuXi AppTec

EVENTS

wuxi-executive-breakfast-in-basel-the-most-important-innovation-in-drug-r-d-may-be-how-the-industry-works-together
WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together
Reflections from the WuXi Executive Breakfast at Swiss Biotech Day
May 11, 2026
READ MORE

FEATURED

© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy